Verastem stock rises on FDA fast track for lung cancer drug
Investing.com Gold reports: Verastem stock rises on FDA fast track for lung cancer drug. Full body text was unavailable at ingest time, so this brief is based on headline context.
Investing.com Gold reports: Verastem stock rises on FDA fast track for lung cancer drug. Full body text was unavailable at ingest time, so this brief is based on headline context.